IL6 and non-small cell lung carcinoma: When compared with healthy controls, NSCLC patients exhibited significantly elevated plasma levels of multiple inflammatory mediators, including IL-6, IL-8, IL-10, IL-17A, and IL-1RA (Figure 2).